Workers who teamed with local pharmacists to better control their diabetes improved their blood glucose numbers and saved their bosses an average of $918 per year in a pilot program developed by the American Pharmacists Association Foundation.
For the third year in a row, a record number of pharmacists had their licenses transferred to other states in 2004, according to an annual year-end review by the National Association of Boards of Pharmacy.
Help is on the way for patients who cannot afford prescription drug care. Pharmacy and pharmaceutical manufacturers have rolled out clearinghouse services to guide pharmacists, prescribers, and the public through the tangle of patient assistance programs (PAPs) that provide free or discounted medications to qualifying patients.
During the annual meeting of the American Pharmacists Association in Orlando, Fla., last month, the house of delegates adopted resolutions on clinical trials, compounding, and methamphetamine precursors. But it passed the buck to the board of trustees on several other issues, including confusing ingredients in some over-the-counter products and a call for a study of mail order as a potential terrorist target.
Sensing that the time has come for the profession to take responsibility for policing what many view as a pharmacist"s cherished prerogative—compounding—Kenneth Baker has accepted the job of implementing a way for compounding pharmacies to earn a stamp of approval from the Pharmacy Compounding Accreditation Board (PCAB).
A 22-year-old woman, L.N., arrived at your emergency department after a "spell." Based on her symptoms and EEG findings, her physician has diagnosed the spell as a complex partial seizure that generalized to a secondary tonic-clonic seizure. L.N.'s neurological exam, physical exam, complete blood count, serum glucose, electrolytes, drug/alcohol screen, and lumber puncture were normal. However, while in the hospital, she experienced a second seizure, prompting her physician to consider antiepileptic drug (AED) therapy. Because L.N. is two months pregnant, her doctor requests a pharmacist consult. What do you recommend?
Uncle Sam has given up to 145 clinical pharmacists the job of reviewing the formularies of drug plan sponsors seeking to be part of the Medicare prescription drug benefit that is set to begin on New Year's Day, 2006.
The always high-interest Late Breaking Clinical Trials at the Annual Scientific Session of the American College of Cardiology, held in Orlando, Fla., were particularly notable this year. First, they included an unprecedented three individual sessions on the antiplatelet agent Plavix (clopidogrel, Sanofi-Aventis). Second, justifying the plunge to lower and lower LDL-cholesterol (LDL-C) targets, they included strong results for a trial of 80 mg of atorvastatin (Lipitor, Pfizer), and, finally, they featured a session with conflicting messages on the risks of COX-2 inhibitors.
Compounding pharmacies were put on the defensive recently after a group of health organizations asked federal regulators to crack down on how the pharmacies market their products.
Interest in pharmacy as a career remains high as the nation's pharmacy schools reported a 54% jump in admission applications and awarded a record number of Pharm.D. degrees last year, according to an annual survey of the profession's educational landscape.